Increased activity of secretory phospholipases A (sPLA) type-II was previously observed in ileum of Crohn's disease (CD). Our aims were to explore the involvement of calcium-independent (i)PLAβ in the release of sPLAs from the human mast cell (MC) line (HMC-1) and investigate expressions of cytosolic (c)PLAα, iPLAβ, sPLA-IIA and sPLA-V in MCs of CD ileum. The release of sPLA was investigated in HMC-1 by immunocytochemistry and ELISA. The expression intensities of PLAs in mucosal MCs, and the proportion of PLA-positive MCs, were investigated in normal ileum and in ileum from patients with CD by immunohistochemistry. The calcium ionophore-stimulated release of sPLA-IIA and sPLA-V from HMC-1 was reduced by the iPLA-inhibitor bromoenol lactone. All four PLAs were detectable in mucosal MCs, both in normal ileum and in CD, but the proportion of iPLAβ-containing mucosal MCs and the expression intensity of sPLA-IIA was increased in CD. Results indicate that iPLAβ is involved in the secretion of sPLAs from HMC-1, and suggest that iPLAβ-mediated release of sPLA from intestinal MCs may contribute to CD pathophysiology. Ex vivo studies on isolated mucosal mast cells are however needed to clarify the precise role of MC PLAs in the inflammatory processes of CD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678282PMC
http://dx.doi.org/10.3390/cells8070672DOI Listing

Publication Analysis

Top Keywords

mucosal mcs
12
secretory phospholipases
8
mast cells
8
crohn's disease
8
spla-iia spla-v
8
release spla
8
normal ileum
8
mcs
6
release
5
ileum
5

Similar Publications

Previous abdominal surgery (PAS) increases risk of small bowel obstruction (SBO) due to adhesions, and appendectomy (appy) is an independent risk factor for abdominal adhesion-related complications. Peritoneal inflammation, e.g.

View Article and Find Full Text PDF

Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling.

J Clin Invest

January 2025

Jeff and Penny Vinik Center for Allergic Disease Research, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Mast cells (MCs) expressing a distinctive protease phenotype (MCTs) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MCTs are phenotypically distinct from subepithelial MCs (MCTCs), signals driving human MCT differentiation and this subset's contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MCT transcriptome in nasal polyps.

View Article and Find Full Text PDF

Similarly to acute intestinal helminth infection, several conditions of chronic eosinophilic type 2 inflammation of mucosal surfaces, including asthma and eosinophilic esophagitis, feature robust expansions of intraepithelial mast cells (MCs). Also the hyperplastic mucosa of nasal polyposis in the context of chronic rhinosinusitis, with or without COX1 inhibitor intolerance, contains impressive numbers of intraepithelial MCs. In this issue of the JCI, Derakhshan et al.

View Article and Find Full Text PDF

Importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis.

J Allergy Clin Immunol

November 2024

Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address:

Article Synopsis
  • IgG can trigger systemic anaphylaxis (SA) in both mice and humans, but the roles of mast cells and histamine in this process are still debated, especially in humans.
  • In experiments with various mouse strains, it was found that histamine from connective tissue mast cells (CTMCs) is crucial for IgG-mediated anaphylaxis, particularly in young mice.
  • The study concludes that the dependence on histamine for anaphylaxis varies based on factors like mouse age, sex, and immune history, suggesting complexity in how IgG-mediated SA operates in different contexts.
View Article and Find Full Text PDF

This article is an abridged version of the updated AWMF mould guideline "Medical clinical diagnostics in case of indoor mould exposure - Update 2023", presented in July 2023 by the German Society of Hygiene, Environmental Medicine and Preventive Medicine (Gesellschaft für Hygiene, Umweltmedizin und Präventivmedizin, GHUP), in collaboration with German and Austrian scientific medical societies, and experts. Indoor mould growth is a potential health risk, even if a quantitative and/or causal relationship between the occurrence of individual mould species and health problems has yet to be established. There is no evidence for a causal relationship between moisture/mould damage and human diseases, mainly because of the ubiquitous presence of fungi and hitherto inadequate diagnostic methods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!